DarioHealthDRIO +1.17%62 Operating Margin % is -130.89% as of Mar. 2026. GuruFocus rates DRIO with a GF Score™ of 62/100 and a GF Value™ of $7.16 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, DarioHealth ranks worse than 92.96% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. DarioHealth's Operating Income for the
three
months ended in Mar. 2026 was $-7.31 Mil. DarioHealth's Revenue for the
three
months ended in Mar. 2026 was $5.58 Mil. Therefore, DarioHealth's Operating Margin % for the quarter that ended in Mar. 2026 was -130.89%.
Good Sign:
DarioHealth Corp operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for DarioHealth's Operating Margin % or its related term are showing as below:
DRIO'
s Operating Margin % Range Over the Past 10 Years
Min: -394.71 Med: -257.66 Max: -163.07
Current: -163.07
DRIO's Operating Margin % is ranked worse than 92.96% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 4.845
vs DRIO: -163.07
DarioHealth's 5-Year Average Operating Margin % Growth Rate was 15.20% per year.
DarioHealth's Operating Income for the
three
months ended in Mar. 2026 was $-7.31 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was $-34.56 Mil.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
DarioHealth Operating Margin % Related Terms
DarioHealth Operating Margin % Historical Data
* Premium members only.
The historical data trend for DarioHealth's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DRIO vs BEAT, ONMD, VASO: Operating Margin % Comparison
For the Health Information Services subindustry, DarioHealth's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DarioHealth Operating Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's Operating Margin % distribution charts can be found below:
* The bar in red indicates where DarioHealth's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
DarioHealth's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DarioHealth (DRIO) has a Operating Margin % of -130.89% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on DarioHealth and its competitors. According to the industry distribution chart, DarioHealth ranks #621 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 93%.
Is DarioHealth's Operating Margin % too high?
DarioHealth's current Operating Margin % is -130.89%. Based on the distribution chart, DarioHealth ranks #621 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, DarioHealth has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DarioHealth's Operating Margin % compare to BEAT and ONMD?
According to the Healthcare Providers & Services industry distribution chart, DarioHealth ranks #621 out of 668 companies for Operating Margin %. This places DarioHealth in the lower half of its industry. The industry median Operating Margin % is 4.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.85, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on DarioHealth and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DarioHealth's current Operating Margin % is -130.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DarioHealth stock overvalued right now?
Based on GuruFocus' analysis, DarioHealth (DRIO) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.16, compared to a current price of $6.06 — trading 15.4% below its estimated fair value. The current Operating Margin % is -130.89%. DarioHealth's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For DarioHealth (DRIO), the current Operating Margin % is -130.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DarioHealth (DRIO) Overvalued in 2026?
Based on GuruFocus' analysis, DarioHealth stock appears to be undervalued.
The current stock price of $6.06 is trading 15.4% below its estimated GF Value™ of $7.16.
GuruFocus considers DarioHealth to be Modestly Undervalued.
Key valuation signals for DRIO:
Operating Margin %: -130.89%
GF Value™: $7.16 vs. price of $6.06 (15.4% below fair value)
No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
62GF Score
Get the complete analysis for DRIO
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DRIO has been successfully added to your 
